Completed NA INTERVENTIONAL 2-arm NCT02957838

Mitochondrial Effects of C18:0 Supplementation in Humans

Mitochondrial Effects of C18:0 Supplementation in Type 2 Diabetics Versus Healthy Controls

Sponsor: German Cancer Research Center

Conditions Alteration of Mitochondrial Membrane Fatty Acid Deficiency Type2 Diabetes

Interventions C18:0 mock

Updated 6 times since 2017 Last updated: Nov 23, 2017 Started: Nov 30, 2016 Primary completion: Oct 6, 2017 Completion: Nov 18, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alteration of Mitochondrial Membrane and Fatty Acid Deficiency and is currently completed. German Cancer Research Center leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Dec 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Dec 2017 [monthly]

Recruiting NA

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

German Cancer Research Center
University Hospital Heidelberg

Data source: University Hospital Heidelberg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Heidelberg, Germany